Blood, brain tissue and cerebrospinal fluid pharmacokinetics of the antidepressant Mirtazapine in rats

被引：0
|
作者：
Kandikere, Vishwottam N. [1 ]
Mudigonda, Koteshwara [1 ]
Bhyrapuneni, Gopinadh [1 ]
Omtri, Rajesh S. [1 ]
Muddana, Nageswararao [1 ]
Mettu, Vijayasaradhi [1 ]
Reddy, Jagadeeshchandra [1 ]
Nirogi, Ramakrishna V. S. [1 ]
机构：
[1] Suven Life Sci Ltd, Serene Chambers, Discovery Res, Hyderabad 500034, Andhra Pradesh, India
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 231卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
151-ANYL
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effect of nitazoxanide on albendazole pharmacokinetics in cerebrospinal fluid and plasma in rats
    Isabel Ruiz-Olmedo, Maria
    Gonzalez-Hernandez, Iliana
    Palomares-Alonso, Francisca
    Franco-Perez, Javier
    de Lourdes Gonzalez F, Maria
    Jung-Cook, Helgi
    SAUDI PHARMACEUTICAL JOURNAL, 2017, 25 (03) : 413 - 418
  • [22] PHARMACOKINETICS OF LITHIUM IN BRAIN, CEREBROSPINAL-FLUID AND SERUM OF RAT
    WRAAE, O
    BRITISH JOURNAL OF PHARMACOLOGY, 1978, 64 (02) : 273 - 279
  • [23] Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma
    Zylber-Katz, E
    Gomori, JM
    Schwartz, A
    Lossos, A
    Bokstein, F
    Siegel, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (06) : 631 - 641
  • [24] ANTIEPILEPTIC DRUG PHARMACOKINETICS AND NEUROPHARMACOKINETICS IN INDIVIDUAL RATS BY REPETITIVE WITHDRAWAL OF BLOOD AND CEREBROSPINAL-FLUID - MILACEMIDE
    SEMBA, J
    CURZON, G
    PATSALOS, PN
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (04) : 1117 - 1124
  • [25] Considerations in the Use of Cerebrospinal Fluid Pharmacokinetics to Predict Brain Target Concentrations in the Clinical SettingImplications of the Barriers Between Blood and Brain
    Elizabeth C.M. de Lange
    Meindert Danhof
    Clinical Pharmacokinetics, 2002, 41 : 691 - 703
  • [26] ANTIEPILEPTIC DRUG PHARMACOKINETICS AND NEUROPHARMACOKINETICS IN INDIVIDUAL RATS BY REPETITIVE WITHDRAWAL OF BLOOD AND CEREBROSPINAL-FLUID - PHENYTOIN
    LOLIN, YI
    RATNARAJ, N
    HJELM, M
    PATSALOS, PN
    EPILEPSY RESEARCH, 1994, 19 (02) : 99 - 110
  • [27] The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction
    Britta Engelhardt
    Lydia Sorokin
    Seminars in Immunopathology, 2009, 31 : 497 - 511
  • [28] DISTRIBUTION OF THE ANTICONVULSANT FELBAMATE TO CEREBROSPINAL-FLUID AND BRAIN-TISSUE OF ADULT AND NEONATAL RATS
    ADUSUMALLI, VE
    WICHMANN, JK
    KUCHARCZYK, N
    SOFIA, RD
    DRUG METABOLISM AND DISPOSITION, 1993, 21 (06) : 1079 - 1085
  • [29] BRAIN AND CEREBROSPINAL-FLUID DISTRIBUTIONS OF METOPROLOL IN RATS
    NAKAZONO, T
    MURAKAMI, T
    SAKAI, S
    HIGASHI, Y
    YATA, N
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1992, 15 (06): : 295 - 302
  • [30] COMPARATIVE DETERMINATIONS OF COCAINE AND ITS METABOLITES IN BLOOD, CEREBROSPINAL-FLUID AND BRAIN-TISSUE
    NOWAK, R
    BALABANOVA, S
    ODENWALLER, U
    ZEITSCHRIFT FUR RECHTSMEDIZIN-JOURNAL OF LEGAL MEDICINE, 1989, 102 (07): : 445 - 450
12345